GLP-1R agonists clinical trial design needs to be improved to reassure drugs’ benefits: GlobalData Read more
Top 20 global biopharma companies report 9.6 per cent market cap growth in Q1 2024: GlobalData Read more
Alzheon’s oral anti-amyloid drug has potential to be first oral Aβ-targeting therapy approved in US and EU: GlobalData Read more
CRISPR-based innovations drive $21 bn in pharma licensing deals over five years: GlobalData Read more
